HBI
52
3
NVDA
52
2
NOV
38
4
ISRG
66
3
PCAR
39
9
PEP
33
-6
CMG
50
2
DLTR
52
-4
JPM
66
3
GLW
50
2
SO
57
-2
CMI
51
2
PLD
37
5
MTCH
50
4
ZBH
54
4
EXPD
29
5
AES
34
2
MTB
63
3
MHK
58
10
PAYX
51
4
HBI
52
3
NVDA
52
2
NOV
38
4
ISRG
66
3
PCAR
39
9
PEP
33
-6
CMG
50
2
DLTR
52
-4
JPM
66
3
GLW
50
2
SO
57
-2
CMI
51
2
PLD
37
5
MTCH
50
4
ZBH
54
4
EXPD
29
5
AES
34
2
MTB
63
3
MHK
58
10
PAYX
51
4
Financhill
Back

JPMorgan Chase & Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
66

JPM
JPMorgan Chase &

Last Price:
$243.49
Seasonality Move:
1.31%
Buy
66

SRPT
Sarepta Therapeutics

Last Price:
$60.45
Seasonality Move:
13.61%
Buy
66
JPMorgan Chase & (JPM) is a Buy

Is JPMorgan Chase & a Buy, Sell or Hold?

  • The current JPMorgan Chase & [JPM] share price is $244.64. The Score for JPM is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • JPM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $61.76. The Score for SRPT is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

JPM Stock Price Chart

What is JPMorgan Chase &'s stock price today?

  • The JPMorgan Chase & share price today is $244.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JPM is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $61.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

JPM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.6 Sell
Relative Strength Index (14 RSI): 56.03 Buy
Chaikin Money Flow: 7119736 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (225.36 - 246.96) Buy
Bollinger Bands (100): (232.85 - 263.19) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.72 Sell
Relative Strength Index (14 RSI): 44.97 Sell
Chaikin Money Flow: 1413454 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.5 - 69.5) Buy
Bollinger Bands (100): (75.99 - 127.65) Sell

JPM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 234.94 Buy
20-day SMA: 233.66 Buy
50-day SMA: 245.65 Sell
200-day SMA: 232.44 Buy
8-day EMA: 236.26 Buy
20-day EMA: 235.62 Buy
50-day EMA: 241.06 Buy
200-day EMA: 231.27 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.57 Buy
20-day SMA: 57.74 Buy
50-day SMA: 81.94 Sell
200-day SMA: 116.58 Sell
8-day EMA: 57.69 Buy
20-day EMA: 61.26 Buy
50-day EMA: 77.18 Sell
200-day EMA: 106.29 Sell

JPMorgan Chase & Earnings Growth & JPM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.46 per share, an increase this year of $0.01 per share, and an increase next year of $1.10 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.28 per share, a decrease next quarter of $0.51 per share, an increase this year of $3.58 per share, and an increase next year of $6.23 per share.

JPMorgan Chase & Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):